BALYASNY ASSET MANAGEMENT L.P. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$19,575
-53.0%
22,562
+84.2%
0.00%
Q4 2022$41,647
-98.7%
12,249
-97.9%
0.00%
-100.0%
Q3 2022$3,252,000
+738.1%
595,558
+592.0%
0.01%
+900.0%
Q2 2022$388,000
-84.6%
86,059
-74.9%
0.00%
-87.5%
Q1 2022$2,524,000
+116.5%
342,484
+70.9%
0.01%
+60.0%
Q3 2021$1,166,000
+127.7%
200,412
+303.7%
0.01%
+150.0%
Q2 2021$512,000
-83.3%
49,649
-82.9%
0.00%
-86.7%
Q1 2021$3,063,000
-45.4%
291,187
-19.7%
0.02%
-51.6%
Q4 2020$5,612,000
+32.9%
362,505
+62.5%
0.03%
-16.2%
Q2 2020$4,224,000
+985.9%
223,043
+437.9%
0.04%
+1133.3%
Q4 2018$389,000
-39.3%
41,465
+10.1%
0.00%0.0%
Q3 2018$641,000
+235.6%
37,660
+161.5%
0.00%
+200.0%
Q4 2015$191,000
+6.1%
14,400
-15.8%
0.00%0.0%
Q3 2015$180,000
-94.8%
17,100
-82.8%
0.00%
-96.3%
Q3 2014$3,481,00099,6310.03%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,827,078$82,205,0004.43%
Palo Alto Investors LP 4,663,324$79,416,0003.21%
Private Capital Advisors, Inc. 473,901$8,071,0002.23%
DOHENY ASSET MANAGEMENT /CA 215,445$3,669,0001.92%
Sandia Holdings, LLC 119,739$2,039,0000.96%
Capital Impact Advisors, LLC 102,006$1,744,0000.60%
Birchview Capital, LP 50,000$852,0000.55%
EMERALD ADVISERS, LLC 694,068$11,820,0000.43%
EMERALD MUTUAL FUND ADVISERS TRUST 647,307$11,024,0000.37%
Schonfeld Strategic Advisors LLC 418,100$7,121,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders